XML 105 R24.htm IDEA: XBRL DOCUMENT
v2.4.1.9

Accumulated Other Comprehensive Income (Loss) | 12 Months Ended
--- | ---
Dec. 31, 2014
Equity [Abstract] |
Accumulated Other Comprehensive (Loss) Income | Accumulated Other Comprehensive (Loss) Income: The components and activity in Accumulated other comprehensive (loss) income consisted of the following during the years ended December 31, 2014, 2013 and 2012 (in thousands):
| Foreign Currency Translation(a) |  | Pension and Post-Retirement Benefits(b) |  | Net Investment Hedge(c) |  | Interest Rate Swap(d) |  | Other |  | Total
Balance at December 31, 2011 | $ | 56,245 |  |  | $ | 5,060 |  |  | $ | — |  |  | $ | — |  |  | $ | (976 | ) |  | $ | 60,329 |
Current period change | 26,846 |  |  | (6,533 | ) |  | — |  |  | — |  |  | 212 |  |  | 20,525 |
Tax benefit (expense) | 2,026 |  |  | 2,462 |  |  | — |  |  | — |  |  | (78 | ) |  | 4,410 |
Balance at December 31, 2012 | 85,117 |  |  | 989 |  |  | — |  |  | — |  |  | (842 | ) |  | 85,264 |
Current period change | 29,539 |  |  | (781 | ) |  | — |  |  | — |  |  | 214 |  |  | 28,972 |
Tax benefit (expense) | 1,809 |  |  | 279 |  |  | — |  |  | — |  |  | (79 | ) |  | 2,009 |
Balance at December 31, 2013 | 116,465 |  |  | 487 |  |  | — |  |  | — |  |  | (707 | ) |  | 116,245 |
Current period change | (163,456 | ) |  | (772 | ) |  | 17,971 |  |  | (33,091 | ) |  | 217 |  |  | (179,131 | )
Tax benefit (expense) | (5,273 | ) |  | 285 |  |  | (6,587 | ) |  | 12,129 |  |  | (81 | ) |  | 473 |
Balance at December 31, 2014 | $ | (52,264 | ) |  | $ | — |  |  | $ | 11,384 |  |  | $ | (20,962 | ) |  | $ | (571 | ) |  | $ | (62,413 | )
(a) | Current period change for the year ended December 31, 2012 includes $12.3 million related to a non-cash write-off of foreign currency translation adjustments from Accumulated other comprehensive (loss) income in connection with our exit of the phosphorus flame retardants business. See Note 20, “Restructuring and Other.” Current period change for the year ended December 31, 2014 includes $17.8 million related to a non-cash write-off of foreign currency translation adjustments from Accumulated other comprehensive (loss) income in connection with the sale of our antioxidant, ibuprofen and propofol businesses and assets which closed on September 1, 2014. See Note 2, “Discontinued Operations.”
(b) | Current period change for the year ended December 31, 2012 includes $6.5 million related to a supplemental executive retirement plan settlement in connection with the retirement of our former CEO and executive chairman, and ($4.5) million related to various amendments to certain of our U.S. pension and defined contribution plans that were approved by our Board of Directors in the fourth quarter of 2012.
(c) | Current period change for the year ended December 31, 2014 includes $12.8 million related to the revaluation of our euro-denominated senior notes and a $5.2 million gain on the settlement of related foreign currency forward contracts, both of which were designated as a hedge of our net investment in foreign operations. See Note 13, “Long-Term Debt” for additional information about these transactions.
(d) | Current period change for the year ended December 31, 2014 includes a realized loss of ($33.4) million on the settlement of our forward starting interest rate swap which was designated and accounted for as a cash flow hedge under ASC 815, Derivatives and Hedging. See Note 13, “Long-Term Debt” for additional information about this interest rate swap.
In accordance with accounting guidance issued by the FASB in February 2013 which became effective for us in the first quarter of 2013 on a prospective basis, below is information about amounts reclassified from accumulated other comprehensive (loss) income, net of deferred income taxes, for the years ended December 31, 2014 and 2013 (in thousands):
| Foreign Currency Translation(a) |  | Pension and Post-Retirement Benefits(b) |  | Net Investment Hedge |  | Interest Rate Swap(c) |  | Other |  | Total
Accumulated other comprehensive income (loss) - balance at December 31, 2012 | $ | 85,117 |  |  | $ | 989 |  |  | $ | — |  |  | $ | — |  |  | $ | (842 | ) |  | $ | 85,264 |
Other comprehensive income (loss) before reclassifications | 31,704 |  |  | — |  |  | — |  |  | — |  |  | (2 | ) |  | 31,702 |
Amounts reclassified from accumulated other comprehensive income (loss) | — |  |  | (502 | ) |  | — |  |  | — |  |  | 137 |  |  | (365 | )
Other comprehensive income (loss), net of tax | 31,704 |  |  | (502 | ) |  | — |  |  | — |  |  | 135 |  |  | 31,337 |
Other comprehensive income attributable to noncontrolling interests | (356 | ) |  | — |  |  | — |  |  | — |  |  | — |  |  | (356 | )
Accumulated other comprehensive income (loss) - balance at December 31, 2013 | $ | 116,465 |  |  | $ | 487 |  |  | $ | — |  |  | $ | — |  |  | $ | (707 | ) |  | $ | 116,245 |
Other comprehensive (loss) income before reclassifications | (151,059 | ) |  | — |  |  | 11,384 |  |  | (21,174 | ) |  | — |  |  | (160,849 | )
Amounts reclassified from accumulated other comprehensive income (loss) | (17,750 | ) |  | (487 | ) |  | — |  |  | 212 |  |  | 136 |  |  | (17,889 | )
Other comprehensive (loss) income, net of tax | (168,809 | ) |  | (487 | ) |  | 11,384 |  |  | (20,962 | ) |  | 136 |  |  | (178,738 | )
Other comprehensive loss attributable to noncontrolling interests | 80 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 80 |
Accumulated other comprehensive (loss) income - balance at December 31, 2014 | $ | (52,264 | ) |  | $ | — |  |  | $ | 11,384 |  |  | $ | (20,962 | ) |  | $ | (571 | ) |  | $ | (62,413 | )
(a) | Amounts reclassified from accumulated other comprehensive income (loss) for the year ended December 31, 2014 are included in (Loss) income from discontinued operations (net of tax) and resulted from the release of cumulative foreign currency translation adjustments into earnings upon the sale of our antioxidant, ibuprofen and propofol businesses and assets which closed on September 1, 2014. See Note 2, “Discontinued Operations.”
(b) | The pre-tax portion of amounts reclassified from accumulated other comprehensive (loss) income consists of amortization of prior service benefit, which is a component of pension and postretirement benefits cost (credit). See Note 18, “Pension Plans and Other Postretirement Benefits.”
(c) | The pre-tax portion of amounts reclassified from accumulated other comprehensive (loss) income is included in interest expense. See Note 13, “Long-Term Debt.”

X
- Definition The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 11 -URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e637-108580 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 14 -URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e681-108580 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 15 -URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e689-108580 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 1A -URI http://asc.fasb.org/extlink&oid=36458714&loc=SL7669619-108580 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 12 -URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e640-108580 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 17 -URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e716-108580 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 16 -URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e709-108580 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Reclassification Adjustments -URI http://asc.fasb.org/extlink&oid=6522872 + Details
Name: | us-gaap_ComprehensiveIncomeNoteTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration